ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1042

Identifying Patient Priorities for Patient-Reported Outcome Measures in Rheumatoid Arthritis: A Modified Delphi Consensus Study

Racheal Githumbi1, Steven Katz2, Ania Kania-Richmond1, Kim Giroux3, Yvonne Wallace3, Cheryl Barnabe1, Glen Hazlewood1, C. Allyson Jones2, Amanda Steiman4, Anshula Ambasta1, Diane Lacaille5, Elaine Yacyshyn2, Jessica Widdifield6, Natasha Gakhal7, Tyler Williamson1 and Claire Barber1, 1University of Calgary, Calgary, AB, Canada, 2University of Alberta, Edmonton, AB, Canada, 3Patient Partner, Calgary, AB, Canada, 4Sinai Health System, Toronto, ON, Canada, 5Arthritis Research Canada, University of British Columbia, Vancouver, BC, Canada, 6Sunnybrook Research Institute / ICES / UofT Institute of Health Policy, Management & Evaluation, Toronto, ON, Canada, 7Women's College Hospital, Toronto, ON, Canada

Meeting: ACR Convergence 2024

Keywords: Health Services Research, Patient reported outcomes, quality of care, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Health Services Research – ACR/ARP Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Patient-reported outcome measures (PROMs) are essential tools for prioritizing patient-centric care and enhancing health system-performance measurement in rheumatology. Effective use of PROMs collected in clinical care hinges on selecting appropriate measures. The expansion of available PROMs applicable for use in rheumatologic conditions complicates this selection process. Additionally, their use at the point of care remains limited due to barriers in clinical workflows. Engaging patients in the selection process can mitigate these barriers.

The aim of this study was to examine patient preferences and prioritize PROMs for routine collection in RA care as part of a broader health-system quality improvement program.

Methods: We used a modified Delphi consensus approach with a panel of volunteer RA patients. Candidate PROMs were identified through an environmental scan focused on measures relevant to individuals living with RA, including the Patient-Reported Outcomes Measurement Information System (PROMIS). Candidate PROMs met the following criteria: 1) clinical and/or research evidence supporting their use in RA, 2) valid psychometric properties, 3) available at no cost, and 4) feasible to complete in routine care.

As members of the investigative team, two RA patient co-leads contributed to the study preparatory work and co-facilitation. Additional RA patient volunteers were recruited from tertiary rheumatology care centers and patient-advocacy social media platforms. The Modified Delphi process (Figure 1) began with a preliminary round (Round 0) to familiarize patients with the methodology and terms, and to prioritize health domains/outcomes for review. This was followed by three rounds where participants independently reviewed and rated candidate PROMs on a Likert scale of 1-9 for content validity, importance, and feasibility, with a virtual consensus-building discussion in round 2. Consensus was achieved if PROMs received a median rating of 7 or higher in all criteria and were highly ranked (within the top 5) by participants in the final round. Results were analyzed using descriptive statistics and the overall rank was assigned to PROMs in descending order based on the rank-weighted sum.

Results: Fifteen RA patients, including the co-leads, took part in the Delphi rounds. Most were female (67%), 45 years old or younger (53%) with a disease duration of < 10 years (67%). From an initial set of 15 candidate PROMS, 10 were rated highly (≥ 7) across all three criteria in Round 3 (Table 1). PROMs ranked within the top 5 included PROMIS Physical Function, PROMIS Profile, PROMIS Ability to Participate in Social Roles and Activities, PROMIS Global Health, and PROMIS Pain Interference respectively.

Conclusion: Patient engagement is critical to ensure that outcomes addressed in clinical practice are aligned with patients’ preferences and priorities. PROMs prioritized by this RA patient advisory panel spanned multiple health domains.  Our next steps will include consultations with healthcare providers and health system leaders before finalizing on a set of PROMs for implementation in routine practice.

Supporting image 1

Figure 1: Activities of the Modified Delphi Panel

Supporting image 2

Table 1: Candidate PROMs and their Overall Rank.


Disclosures: R. Githumbi: Epic, 2, 3; S. Katz: None; A. Kania-Richmond: None; K. Giroux: None; Y. Wallace: None; C. Barnabe: Amgen, 6, Janssen, 6; G. Hazlewood: None; C. Jones: None; A. Steiman: GSK and AstraZeneca, 6, Pfizer, 5; A. Ambasta: None; D. Lacaille: None; E. Yacyshyn: Otsuka Canada, 6, Sobi, 6; J. Widdifield: None; N. Gakhal: AbbVie/Abbott, 1, 5, 6, AstraZeneca, 1, Eli Lilly, 1, Janssen, 1, Novartis, 1, 6, Pfizer, 1, 5, UCB, 6; T. Williamson: None; C. Barber: None.

To cite this abstract in AMA style:

Githumbi R, Katz S, Kania-Richmond A, Giroux K, Wallace Y, Barnabe C, Hazlewood G, Jones C, Steiman A, Ambasta A, Lacaille D, Yacyshyn E, Widdifield J, Gakhal N, Williamson T, Barber C. Identifying Patient Priorities for Patient-Reported Outcome Measures in Rheumatoid Arthritis: A Modified Delphi Consensus Study [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/identifying-patient-priorities-for-patient-reported-outcome-measures-in-rheumatoid-arthritis-a-modified-delphi-consensus-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/identifying-patient-priorities-for-patient-reported-outcome-measures-in-rheumatoid-arthritis-a-modified-delphi-consensus-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology